Sharon M Weber, MD, FACS
- Chief, Division of Surgical Oncology
- Medical Director of Surgical Oncology, UW Carbone Cancer Center
- Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology
600 Highland Avenue
Box 7375 Clinical Science Center
Madison, Wisconsin 53792-3284
- MD, University of Wisconsin Medical School, Madison, WI, 1993
- Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
- Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
- Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
- Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001
Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.
Dr. Weber provides a wide range of services including Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Cytoreductive Surgery with HIPEC, Frey Procedure, Gastrectomy – Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Liver Resection, Liver Resection, Liver Tumor Ablations, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, Radical Cholecystectomy, Radiofrequency Ablation, Right Hemihepatectomy, Right / Left Extended Hemihepatectomy (Hepatectomy), Wedge Resection of the Liver, Whipple Procedure.
Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.
- Smoking and gastrointestinal cancer patients-is smoking cessation an attainable goal?
- Barrett JR, Cherney-Stafford L, Alagoz E, Piper ME, Cook J, Campbell-Flohr S, Weber SM, Winslow ER, Ronnkleiv-Kelly SM, Abbott DE
- J Surg Oncol 2019 Oct 31;
- [PubMed ID: 31674041]
- Correction to: Current Approaches in the Management of Hepatic Adenomas.
- Tsilimigras DI, Rahnemai-Azar AA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM
- J. Gastrointest. Surg. 2019 Oct 10;
- [PubMed ID: 31602557]
- Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.
- Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM, other members of the US Neuroendocrine Tumor Study Group
- J Surg Oncol 2019 Dec; 120(7): 1071-1079
- [PubMed ID: 31571225]
- Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.
- Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM
- Surg Oncol 2019 Sep 13; 31: 83-89
- [PubMed ID: 31541911]
- Natural history and cost analysis of surgical bypass versus endoscopic stenting for the palliative management of malignant gastric outlet obstruction.
- Fisher AV, Hanlon B, Fernandes-Taylor S, Schumacher JR, Lawson EH, Ronnekleiv-Kelly SM, Minter RM, Weber SM, Abbott DE
- HPB (Oxford) 2019 Sep 10;
- [PubMed ID: 31519358]